Reuters: Health
Biogen Inc and partner Alkermes Plc said on Wednesday that the U.S. Food and Drug Administration approved their oral drug to treat multiple sclerosis.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
Popular Posts
|
No comments:
Post a Comment